The groundbreaking approach of this peptide represents a significant development in the care of the condition. Unlike existing therapies, tirzepatide targets dual pathways – glucagon-like peptide-1 (GLP-1) and the https://tirzepatide-peptide482938.eedblog.com/42293374/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment